The recent report published by SPER Market Research shared that the global patient registry software market was valued at USD 1.5 Bn in 2021 and estimated to reach USD 3.2 Bn by 2030 with a CAGR of 14.8%.
Globally, shift towards computerized registries is observed to provide better storage, reporting and data sorting. This registry software is used to provide quality healthcare with strategic planning.
Patient registry software are used to maintain records of patient’s data which can be supervised by healthcare providers to prescribe personalized treatment options to the patients as per their predetermined health issues.
Increasing incidence of cancer, chronic disorders and lifestyle disorders are also fuelling the growth of patient registry software market. The regulatory authorities are focusing on the implementation of electronic health record solutions to enhance the quality of healthcare delivery to the patients.
The disease registry market is the largest product segment by share in this market. The large share of this segment is mainly ascribed by rising demand to integrate the healthcare system, usefulness of these software’s to curb disease burden and track patient’s data for clinical trials. North America dominated the market by regional segmentation owing to technological advancement, rising adoption of EHRs and government initiatives to increase implementation of these solution to strengthen healthcare delivery to the population.
The global patient registry software market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as ArborMetrix, Armus, Cedaron, Conduent, Inc., Dacima Software, Elekta AB, ESO Solutions, Evado Clinical, FIGmd, Global Vision Technologies, IBM Corporation, ifa Systems AG, ImageTrend, IQVIA Holdings, Lumdex, McKesson Corporation, Medstreaming- M2S, OpenText Corporation, Optum, Ordinal Data Inc., Phamax AG, Premier, Inc., Syneos Health, Versaform Systems Corp, WIRB Copernicus Group.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for registry type segments-Disease registries (Cardiovascular, diabetes, cancer, rare disease, asthma, chronic kidney disease, orthopaedic, others), Health Service Registries, Product Registries (Medical Device, Drug); for software type-Standalone software and Integrated Software; for pricing model-Subscription, Ownership; for deployment model-On-premise models, Web & Cloud-based models; for database type-commercial and public; for functionality- population Health Management, Patient Care Management, Health Information Exchange, Point-of-care, Product-outcome Evaluation, Medical Research & Clinical Studies; and by End User-government organisation & third-party administrators, hospitals & medical practices, private payers, pharmaceutical, biotechnology, & medical device companies, research centers. This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors for this market for the forecast period. Various growth opportunities are also discussed in the report.